A Pharmaceutico-Analytical And Exploratory Study Of Salsaradi Gana Bhawit Shilajatu In The Management Of Madhumeha
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Change In Subjective And Objective Parameter
研究概览
简要总结
Ayurveda, an ancient system of health care, is based on the knowledge of the Vedas and uses herbal, mineral/metal, and animal substances for therapeutic purposes. A key aspect of Ayurveda, Rasa Shastra, focuses on herbo-mineral formulations (Rasaushadhies), which are known for their faster effects and longer shelf life due to their fine-particle size, allowing them to target specific cells.
Shilajatu, a significant herbo-mineral medication, is highly valued in Ayurveda for its rejuvenating properties, which help delay aging and promote strength. It is noted for its various beneficial components like rasa, uparasa, parada, ratna, and lauha.
The study explores Shilajatu purified with Triphala kwatha and combined with Salsaradi Gana dravya to treat Madhumeha (diabetes mellitus), a metabolic disorder caused by insulin deficiency, leading to symptoms like high blood sugar and frequent urination. Ayurveda offers alternative therapies to manage Madhumeha, and Salsaradi Gana Bhawit Shilajatu enhances Shilajatu’s potency, offering a promising treatment option for the condition.
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- Open Label
入排标准
- 年龄范围
- 30.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient giving the clinical history of Madhumeha Presence of cardinal symptoms of diabetes mellitus eg 3P Polyuria Polydipsia Polyphagia Patient fasting blood sugar level is 126mg per dl to 200mg per dl and Post Prandial Blood Sugar PPBS level is 200mg per dl to 350mg per dl The fresh diagnosed case of type II DM will include.
排除标准
- •Patients below 30 year and above 65 years will be excluded Pregnant women or the women planning to be pregnant in next 6 month lactating mother CVS disorder CAD CNS disorder eg encephalopathy Patient of type II DM who are on insulin therapy Patient of type I DM.
结局指标
主要结局
Change In Subjective And Objective Parameter
时间窗: 90 days
次要结局
- Improvement in Quality of life of Patient(90 days)